BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sampedro F, Marín‐lahoz J, Martínez‐horta S, Pérez‐gonzález R, Pagonabarraga J, Kulisevsky J. CLU rs11136000 Promotes Early Cognitive Decline in Parkinson's Disease. Mov Disord 2020;35:508-13. [DOI: 10.1002/mds.27949] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Janiszewska E, Kmieciak A, Kacperczyk M, Witkowska A, Kratz EM, Rauf A. The Influence of Clusterin Glycosylation Variability on Selected Pathophysiological Processes in the Human Body. Oxidative Medicine and Cellular Longevity 2022;2022:1-25. [DOI: 10.1155/2022/7657876] [Reference Citation Analysis]
2 Berdowska I, Matusiewicz M, Krzystek-korpacka M. HDL Accessory Proteins in Parkinson’s Disease—Focusing on Clusterin (Apolipoprotein J) in Regard to Its Involvement in Pathology and Diagnostics—A Review. Antioxidants 2022;11:524. [DOI: 10.3390/antiox11030524] [Reference Citation Analysis]
3 Torvell M, Carpanini SM, Daskoulidou N, Byrne RAJ, Sims R, Morgan BP. Genetic Insights into the Impact of Complement in Alzheimer’s Disease. Genes 2021;12:1990. [DOI: 10.3390/genes12121990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Martínez-Horta S, Bejr-Kasem H, Horta-Barba A, Pascual-Sedano B, Santos-García D, de Deus-Fonticoba T, Jesús S, Aguilar M, Planellas L, García-Caldentey J, Caballol N, Vives-Pastor B, Hernández-Vara J, Cabo-Lopez I, López-Manzanares L, González-Aramburu I, Ávila-Rivera MA, Catalán MJ, López-Díaz LM, Puente V, García-Moreno JM, Borrué C, Solano-Vila B, Álvarez-Sauco M, Vela L, Escalante S, Cubo E, Carrillo-Padilla F, Martínez-Castrillo JC, Sánchez-Alonso P, Alonso-Losada MG, López-Ariztegui N, Gastón I, Blázquez-Estrada M, Seijo-Martínez M, Rúiz-Martínez J, Valero-Merino C, Kurtis M, de Fábregues-Boixar O, González-Ardura J, Prieto-Jurczynska C, Martinez-Martin P, Mir P, Kulisevsky J; COPPADIS Study Group. Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson's disease. BMC Neurol 2021;21:477. [PMID: 34879838 DOI: 10.1186/s12883-021-02485-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 G N S HS, Marise VLP, Satish KS, Yergolkar AV, Krishnamurthy M, Ganesan Rajalekshmi S, Radhika K, Burri RR. Untangling huge literature to disinter genetic underpinnings of Alzheimer's Disease: A systematic review and meta-analysis. Ageing Res Rev 2021;71:101421. [PMID: 34371203 DOI: 10.1016/j.arr.2021.101421] [Reference Citation Analysis]
6 Ma X, Wang Y, Yin H, Hua L, Zhang X, Xiao J, Yuan Q, Wang S, Liu Y, Zhang S, Wang Y. Down-regulated long non-coding RNA RMST ameliorates dopaminergic neuron damage in Parkinson's disease rats via regulation of TLR/NF-κB signaling pathway. Brain Res Bull 2021;174:22-30. [PMID: 33933526 DOI: 10.1016/j.brainresbull.2021.04.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Rodríguez-rivera C, Garcia MM, Molina-álvarez M, González-martín C, Goicoechea C. Clusterin: Always protecting. Synthesis, function and potential issues. Biomedicine & Pharmacotherapy 2021;134:111174. [DOI: 10.1016/j.biopha.2020.111174] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Chaplot K, Jarvela TS, Lindberg I. Secreted Chaperones in Neurodegeneration. Front Aging Neurosci 2020;12:268. [PMID: 33192447 DOI: 10.3389/fnagi.2020.00268] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]